'''Glicaramide''' ('''SQ-65993''') is an orally bioavailable [[anti-diabetic]] medication.<ref>{{cite journal | doi = 10.1021/jm00270a006 | title = Potential antidiabetic agents. Pyrazolo[3,4-b]pyridines |author1=Hoehn, H. |author2=Polacek, I. |author3=Schulze, E. | journal = Journal of Medicinal Chemistry  | year = 1973 | volume = 16 | issue = 12 | pages = 1340â€“1346 | pmid = 4358224}}</ref> It has a similar potency as [[glibenclamide]] (glyburide) in the class of medication known as [[sulfonylurea]]s. Its structure is similar since it has a cyclic acyl group which replaces the latter's 2-methoxy-5-chlorobenzyl.<ref>{{cite book |year=1981 |title=Progress in Medicinal Chemistry, Volume 18 (v. 18) (Hardcover)  |url=https://books.google.com/books?id=FC9pDtB_tz0C&pg=PA202&dq |publisher=Elsevier Science |location= |isbn=0-444-80345-9}}</ref> Same as glibenclamide, it is classified as a second-generation sulfonylurea. It may have more pronounced extra-pancreatic effects than glibenclamide or [[tolbutamide]].<ref>{{cite book|last1=West|first1=G.B.|editor1-last=Ellis|editor1-first=GP|title=Progress in medicinal chemistry.|date=Jan 1, 1981|publisher=Elsevier|location=Amsterdam|isbn=9780444803450|page=202|accessdate=12 July 2016}}</ref>
